Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Zambelli

Showing results (91-100 of 162) with videos related to

Pageof 17
Sort By:
Digital Health|November 6, 2024
Digital innovations in breast cancer care: exploring the potential and challenges of digital therapeutics and clinical decision support systemsFlavia Jacobs, Saverio D'Amico, Elena Zazzetti, et al.
Cancers|July 12, 2025
Using [<sup>18</sup>F]FDG PET/CT to Identify Optimal Responders to Neoadjuvant Therapy in Breast Cancer-Results from a Prospective Patient CohortFabrizia Gelardi, Paola Tiberio, Rosalba Torrisi, et al.
Frontiers in Oncology|November 17, 2022
Extended adjuvant endocrine treatment for premenopausal women: A Delphi approach to guide clinical practiceGiuseppe Buono, Grazia Arpino, Lucia Del Mastro, et al.
EMBO Molecular Medicine|December 21, 2013
Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breastAlessandra Rustighi, Alessandro Zannini, Luca Tiberi, et al.
Frontiers in Oncology|November 10, 2018
Two Missense Variants Detected in Breast Cancer Probands Preventing BRCA2-PALB2 Protein InteractionLaura Caleca, Irene Catucci, Gisella Figlioli, et al.
Breast Cancer Research and Treatment|April 30, 2010
Gene expression profiling and prediction of response to hormonal neoadjuvant treatment with anastrozole in surgically resectable breast cancerMaurizia Mello-Grand, Vijay Singh, Chiara Ghimenti, et al.
The British Journal of Surgery|July 20, 2023
Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolmentCorrado Tinterri, Giuseppe Canavese, Wolfgang Gatzemeier, et al.
Bone Marrow Transplantation|October 24, 2021
Long-term survival in a fraction of patients with metastatic breast cancer who received consolidation therapy with high-dose chemotherapy and autologous stem cell transplant between 2000 and 2015: an EBMT registry-based studyMassimo Martino, Annalisa Pitino, Mercedes Gori, et al.
Chronobiology International|September 10, 2008
A randomized multicenter study of optimal circadian time of vinorelbine combined with chronomodulated 5-fluorouracil in pretreated metastatic breast cancer patients: EORTC trial 05971Bruno Coudert, Christian Focan, Dominique Genet, et al.
Breast (Edinburgh, Scotland)|April 18, 2026
Integrating PIK3CA Testing into Clinical Practice for Advanced HR+/HER2- Breast Cancer: An Expert ConsensusCarmine De Angelis, Dario de Biase, Lorenzo Gerratana, et al.
Pageof 17

Showing results (91-100 of 162) with videos related to

Sort By:
Pageof 17
Digital Health|November 6, 2024
Digital innovations in breast cancer care: exploring the potential and challenges of digital therapeutics and clinical decision support systemsFlavia Jacobs, Saverio D'Amico, Elena Zazzetti, et al.
Cancers|July 12, 2025
Using [<sup>18</sup>F]FDG PET/CT to Identify Optimal Responders to Neoadjuvant Therapy in Breast Cancer-Results from a Prospective Patient CohortFabrizia Gelardi, Paola Tiberio, Rosalba Torrisi, et al.
Frontiers in Oncology|November 17, 2022
Extended adjuvant endocrine treatment for premenopausal women: A Delphi approach to guide clinical practiceGiuseppe Buono, Grazia Arpino, Lucia Del Mastro, et al.
EMBO Molecular Medicine|December 21, 2013
Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breastAlessandra Rustighi, Alessandro Zannini, Luca Tiberi, et al.
Frontiers in Oncology|November 10, 2018
Two Missense Variants Detected in Breast Cancer Probands Preventing BRCA2-PALB2 Protein InteractionLaura Caleca, Irene Catucci, Gisella Figlioli, et al.
Breast Cancer Research and Treatment|April 30, 2010
Gene expression profiling and prediction of response to hormonal neoadjuvant treatment with anastrozole in surgically resectable breast cancerMaurizia Mello-Grand, Vijay Singh, Chiara Ghimenti, et al.
The British Journal of Surgery|July 20, 2023
Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolmentCorrado Tinterri, Giuseppe Canavese, Wolfgang Gatzemeier, et al.
Bone Marrow Transplantation|October 24, 2021
Long-term survival in a fraction of patients with metastatic breast cancer who received consolidation therapy with high-dose chemotherapy and autologous stem cell transplant between 2000 and 2015: an EBMT registry-based studyMassimo Martino, Annalisa Pitino, Mercedes Gori, et al.
Chronobiology International|September 10, 2008
A randomized multicenter study of optimal circadian time of vinorelbine combined with chronomodulated 5-fluorouracil in pretreated metastatic breast cancer patients: EORTC trial 05971Bruno Coudert, Christian Focan, Dominique Genet, et al.
Breast (Edinburgh, Scotland)|April 18, 2026
Integrating PIK3CA Testing into Clinical Practice for Advanced HR+/HER2- Breast Cancer: An Expert ConsensusCarmine De Angelis, Dario de Biase, Lorenzo Gerratana, et al.
Pageof 17